e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Treatment of continuous positive airway pressure and monitoring of its effects
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Disease characteristics and adherence to treatment with continous positive airway pressure in men and women severe obstructive sleep apnea (OSA).
P. Bielicki (Warsaw, Poland), A. Pryc (WarsawWarsaw, Poland), A. Witkowska (WarsawWarsaw, Poland), A. Trojnar (WarsawWarsaw, Poland), M. Wasik (WarsawWarsaw, Poland)
Source:
International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Session:
Treatment of continuous positive airway pressure and monitoring of its effects
Session type:
Thematic Poster
Number:
4161
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Bielicki (Warsaw, Poland), A. Pryc (WarsawWarsaw, Poland), A. Witkowska (WarsawWarsaw, Poland), A. Trojnar (WarsawWarsaw, Poland), M. Wasik (WarsawWarsaw, Poland). Disease characteristics and adherence to treatment with continous positive airway pressure in men and women severe obstructive sleep apnea (OSA).. 4161
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
Source: Sleep and Breathing Conference 2021
Year: 2021
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA).
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020
Adherence to continuous positive airway pressure in women with obstructive sleep apnoea
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017
Evaluation of continuous positive airway pressure compliance in a group of obstructive sleep apnea patients
Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology
Year: 2012
Continuous positive airway pressure adherence declines with age in elderly obstructive sleep apnoea patients
Source: ERJ Open Res, 5 (1) 00178-2018; 10.1183/23120541.00178-2018
Year: 2019
Twenty years compliance with continuous positive air pressure treatment in patients with severe obstructive sleep apnea
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019
Efficacy of continuous positive airway pressure treatment to resistant hypertension in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008
Adherence to positive airway pressure in non-sleepy patients with obstructive sleep apnoea
Source: Eur Respir J 2013; 42: 863-866
Year: 2013
Effects of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea syndromes (OSAS)
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
Index for comfort of patients with obstructive sleep apnea on continuous positive airway pressure therapy
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008
Predictors of continuous positive airway pressure adherence in obstructive sleep apnea syndrome
Source: International Congress 2017 – Inhalers and their use
Year: 2017
Association between obstructive sleep apnea (OSA) and depression and the effect of continuous positive airway pressure (CPAP) treatment
Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology
Year: 2012
Impact of humidification on compliance and side effects in obstructive sleep apnea (OSA) patients under auto continuous positive airway pressure (ACPAP) therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 409s
Year: 2006
Prevalence and determinants of residual excessive daytime sleepiness (RES) in patients treated with continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA).
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020
Predictive factors for stopping use of continuous positive airway pressure (CPAP): an observational cohort of 6938 treated obstructive sleep apnea syndrome (OSAS) patients
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007
Comparison of auto-adjusting and fixed positive airway pressure therapy in patients with mild to moderate obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2003; 22: Suppl. 45, 95s
Year: 2003
Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients?
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years
Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea
Year: 2006
Prediction of effective continuous positive airway pressure (CPAP) in obstructive sleep apnea syndrome (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 111s
Year: 2005
Outcomes in patients with REM-related obstructive sleep apnoea (REM-OSA) treated with continuous positive airway pressure (CPAP)
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept